| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/01/2002 | US6335460 Treating retroviral infections, including human immunodeficiency virus, and aids |
| 01/01/2002 | US6335459 Prostaglandin i2 receptor modulators; treating tissue necrosis, premature uterine contraction, gastric ulceration, sexual dysfunction, menstrual pain and improper wound healing, immunoregulation, platelet aggregation or neutrophil function |
| 01/01/2002 | US6335451 Five-membered heterocycles having biphenylsulfonyl substitution, with sulfonylcyanamide side chain, compositions containing them, and methods of using them |
| 01/01/2002 | US6335448 Method for the synthesis of quinoline derivatives |
| 01/01/2002 | US6335445 Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 01/01/2002 | US6335441 5β-cyano-substituted steroid compounds |
| 01/01/2002 | US6335436 Antisense oligonucleotide coupled to ligand such as d-cycloserine, d-glucosamine, or biotin which binds to receptor on mycobacterium; hybridizes to aspartokinase or aspartate semialdehyde dehydrogenase genes |
| 01/01/2002 | US6335433 nrdD |
| 01/01/2002 | US6335424 ribG |
| 01/01/2002 | US6335372 Administering 1,7,7-trimethyl-bicyclo(2.2.1)heptane derivatives, or their pharmaceutically acceptable acid addition salts |
| 01/01/2002 | US6335371 Administering 1,7,7-trimethylbicyclo(2.2.1)heptane derivative such as deramciclane to treat psychological, anxiety, nervous sytem and aging disorders |
| 01/01/2002 | US6335369 Administering l-carnitine fumarate by injection at conclusion of dialysis |
| 01/01/2002 | US6335368 Use of alverine for reducing wrinkles |
| 01/01/2002 | US6335366 A prostaglandin e2 antagonist or agonist which comprises a naphthylhydroxy derivatives or naphthyloxyalkylene derivatives or nontoxic salts |
| 01/01/2002 | US6335365 Fireproof, non-exploding nitroglycerine and solid mixtures containing anhydrous lactose |
| 01/01/2002 | US6335363 Administering 4-(sulfonylamino-)-chromane derivative as insecticide, nematocide, fungicide or pesticide for crop protection |
| 01/01/2002 | US6335361 Method of treating benign forgetfulness |
| 01/01/2002 | US6335360 Indoline-2-carboxylic amide derivatives; obesity, eating and psychological disorders |
| 01/01/2002 | US6335359 Topically applying to skin or scalp to treat dermatitis or acne; side effect reduction |
| 01/01/2002 | US6335358 Lactacystin analogs |
| 01/01/2002 | US6335356 Method of treating a patient by parenteral administration of a lipophilic compound |
| 01/01/2002 | US6335354 Aminopyridines and methods of using thereof |
| 01/01/2002 | US6335353 3-hydroxypyridin-4-one derivative; iron deficiency anemia and thalassemia treatment |
| 01/01/2002 | US6335352 Administering heterocyclic cyanoguanidine derivatives as chemokine inhibitors |
| 01/01/2002 | US6335351 Antiulcer agents and antisecretory agents of gastric juice; gastrointestinal disorder and psoriasis treatment; adenosine triphosphatase inhibitors |
| 01/01/2002 | US6335350 Acetamide and substituted acetamide-containing thiourea inhibitors of herpes viruses |
| 01/01/2002 | US6335349 Agents that reduce levels of tumor necrosis factor; anticarcinogenic and antiinflammatory agents; treatment of autoimmune diseases |
| 01/01/2002 | US6335348 Administering pipecolic acid derivative as cognition activator and to treat eye and nervous system disorders |
| 01/01/2002 | US6335346 Pyrrolo-(3,4-b)quinoline derivatives, method for the production and use thereof as a medicament |
| 01/01/2002 | US6335345 Spiro compounds |
| 01/01/2002 | US6335343 Inhibitors of prenyl-protein transferase |
| 01/01/2002 | US6335342 Azaindole derivatives, process for their preparation, and their use as antitumor agents |
| 01/01/2002 | US6335341 Anticholesterol agents; atherosclerosis |
| 01/01/2002 | US6335340 compounds of heteroaryl substituted imidazole, their pharmaceutical compositons and uses |
| 01/01/2002 | US6335339 Triazine antiviral compounds |
| 01/01/2002 | US6335338 Calcilytic compounds |
| 01/01/2002 | US6335337 Substituted piperazinones and their therapeutic uses |
| 01/01/2002 | US6335336 Treating tumor necrosis factor and mitogen-activated protein kinase(map) mediated disorders; antiinflammatory and antiarthritic agents; inflammatory bowel disease |
| 01/01/2002 | US6335334 Hypertensive agents, anticoagulants; cardiovascular and sexual disorders, angina pectoris, and atherosclerosis |
| 01/01/2002 | US6335333 Matrix metalloproteinase inhibitors |
| 01/01/2002 | US6335332 Barbituric acid derivatives with antimetastatic and antitumor activity |
| 01/01/2002 | US6335331 Antihistamines, antiallergens, brochodilator agents and antispasmodic agents |
| 01/01/2002 | US6335330 7-((4,4*-bipiperidin-1-yl)carbonyl)-2,3,4,5-tetrahydro-4--meth yl-3-oxo-1h-1,4-benzodiazepine-2-acetic acid hydrochloride; fibrinogen receptor antagonits, anticoagulants; prevention of strokes, restenosis |
| 01/01/2002 | US6335329 Carboxylic acid substituted heterocycles, derivatives thereof and methods of use |
| 01/01/2002 | US6335328 Process for the isolation of galanthamine |
| 01/01/2002 | US6335327 1-benzazepine derivatives; agonists or antagonists of vasopressin and/or oxytocin |
| 01/01/2002 | US6335326 Dopamine agonist and antagonists; central nervous system and psychological disorders; anxiolytic, antidepressant and antiischemic agents; parkinson*s disease |
| 01/01/2002 | US6335322 Therapeutic agents |
| 01/01/2002 | US6335321 Non-steroidal anti-inflammatory agent therapy for epithelial cell cancer |
| 01/01/2002 | US6335194 Antisense modulation of survivin expression |
| 01/01/2002 | US6335038 Propionyl l-carnitine and the isoflavone genistein for treatment of osteoporosis and menopause syndrome |
| 01/01/2002 | US6335036 2-phenyl-1,2-benzisoselenazol-3(2h)-one and hydroxypropyl cellulose |
| 01/01/2002 | US6335035 Hyaluronic acid salts blended with hydroxyethylcellulosea and hydroxypropylcellulose; analgesics |
| 01/01/2002 | US6335034 Topical drug preparations |
| 01/01/2002 | US6335033 Melt-extrusion multiparticulates |
| 01/01/2002 | US6335032 Orally administrable solid dosage form |
| 01/01/2002 | US6335031 (s)-n-ethyl-3-(1-dimethylamino)ethyl)-n-methyl-phenyl-carbamat salt form and antioxidant; alzheimer's disease therapy |
| 01/01/2002 | US6335030 Dextromethorphan, 3-methoxy-17-methyl-9a,13a,14a-morphanin, salts, prodrugs metabolites and carriers |
| 01/01/2002 | US6335029 Polymeric coatings for controlled delivery of active agents |
| 01/01/2002 | US6335023 Vehicles and oligosaccharide aldonic acids |
| 01/01/2002 | US6335021 Composition for controlling mood disorders in healthy individuals |
| 01/01/2002 | US6335016 Chicken embryo lethal orphan (CELO) virus |
| 01/01/2002 | US6335015 Administering xanthophylls like astaxanthin fatty acid esters; stability |
| 01/01/2002 | US6335004 Odorless phenolic compositions |
| 01/01/2002 | US6334998 Estrogens for treating ALS |
| 01/01/2002 | US6334445 Intravenously infusing a composition comprising a taxane into the human at continuous dosage over a period of 96 hours for therapy of ovarian cancer |
| 01/01/2002 | CA2285886C Compounds containing oxadiazolopyrimidines destined to be used for slowing down hair loss and for inducing and stimulating their growth |
| 01/01/2002 | CA2235626C Bactericidal permeability increasing protein (bpi) for treating conditions associated with corneal injury |
| 01/01/2002 | CA2215333C Heterocyclic substituted piperazinone derivatives as tachykinin receptor antagonists |
| 01/01/2002 | CA2186337C New amino 5,6,7,8-tetrahydronaphtho¬2,3-b|furane and indano¬5,6-b|furane derivatives; process for preparing the same and pharmaceutical compositions containing them |
| 01/01/2002 | CA2171939C Novel method of progesterone delivery and affect thereof |
| 01/01/2002 | CA2142869C Trifluoromethylpyrroloindolecarboxylic acid ester and process for production thereof |
| 01/01/2002 | CA2093789C Bi-aromatic compounds and their use in human and veterinary medicine and in cosmetic preparations |
| 01/01/2002 | CA2085490C Processes for the manufacture of enriched pitches and carbon fibers |
| 01/01/2002 | CA2083148C Bistriazenes as chemotherapeutic agents |
| 01/01/2002 | CA2082505C Method of treating alopecia |
| 01/01/2002 | CA2067741C 10(1-hydroxyethly)-11-oxo-1-azatricyclo[7.2.0.0.3.8]undec-2-ene-2-carboxylic acid esters and a process for preparing thereof |
| 01/01/2002 | CA2056799C 1,4-dihydropyridine derivatives and methods of producing the same |
| 01/01/2002 | CA2051830C Tricyclic heterocycles |
| 01/01/2002 | CA2051369C Thyroid hormone cardiac treatment |
| 01/01/2002 | CA2048544C Intravascular embolizing agent containing angiogenesis-inhibiting substance |
| 01/01/2002 | CA2042473C Piperidino-nmda antagonists |
| 01/01/2002 | CA2041260C Ultrasonic contrast agents, processes for their preparation and the use thereof as diagnostic and therapeutic agents |
| 01/01/2002 | CA2024849C 4-hydroxytetrahydropyran-2-ones and the corresponding dihydroxycarboxylic acid derivatives, salts and esters, process for their preparation, their use as pharmaceuticals, and pharmaceutical preparations and precursors |
| 01/01/2002 | CA2024156C Compositions for use in controling the shedding of hair and in the induction and stimulation of its growth, such compositions containing 2-amino pyrimidine 3-oxide derivatives andnovel 2-amino pyrimidine 3-oxide derivative compounds |
| 01/01/2002 | CA2023858C (+)-isomers of endoetheno/endoethano-epoxymorphinan derivatives as antitussive agents |
| 01/01/2002 | CA2010217C Aralkylamine compounds |
| 01/01/2002 | CA1341330C Substituted acyl dertivatives of 1,2,3,4-tetrahydroisquinoline-3-carboxylic acids |
| 12/29/2001 | CA2351902A1 Use of growth hormone secretagogues for stimulating or increasing appetite |
| 12/29/2001 | CA2351897A1 Use of growth hormone secretagogues for treatment of physical performance decline |
| 12/28/2001 | CA2312644A1 Pharmaceutical compositions and combinations for the treatment or prophylaxis of disorders related to hiv and retrovirus |
| 12/27/2001 | WO2001099376A2 Arylsulfatase-inhibitors in deodorants and antiperspirants |
| 12/27/2001 | WO2001098543A2 Method of diagnosing, monitoring, staging, imaging and treating breast cancer |
| 12/27/2001 | WO2001098518A2 Biotransformation of biologically active compounds made of various classes of chemical substances by means of laccase and manganese peroxidase enzymes |
| 12/27/2001 | WO2001098511A1 Tumour-cell specific gene expression and its use in cancer therapy |
| 12/27/2001 | WO2001098486A1 Mutation associated with epilepsy |
| 12/27/2001 | WO2001098362A2 Chemically-modified antimicrobial peptides, compositions and methods of production and use |
| 12/27/2001 | WO2001098351A2 G-protein coupled receptors |
| 12/27/2001 | WO2001098346A2 Methods and compositions for the treatment of peripheral artery disease |
| 12/27/2001 | WO2001098344A2 Angiogenesis-modulating compositions and uses |